Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family
- PMID:16876743
- DOI: 10.1016/j.hrthm.2006.04.028
Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family
Abstract
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial disease, with male preponderance, characterized by progressive fibrofatty replacement of the right ventricle and ventricular arrhythmias. Mutations in plakophilin-2 (PKP2), a desmosomal protein, have been reported to underlie familial ARVC. We report a novel ARVC PKP2 mutation and present the clinical findings in three female mutation carriers.
Methods: We sequenced PKP2 from genomic DNA isolated from peripheral blood lymphocytes in a female proband who presented with cardiac arrest and in her four first-degree relatives. Clinical testing and diagnosis of ARVC was based on International Task Force criteria.
Results: The proband was diagnosed with ARVC due to right ventricular enlargement and regional hypokinesis, along with repolarization abnormalities and frequent ventricular ectopy. A novel 28 bp insertion in exon 11 of the PKP2 gene was found which causes a frameshift in the coding region. This results in a change in the amino acid sequence of the protein with a premature stop codon at position 740. Of the four relatives, only the mother and younger sister were identified as mutation carriers. The mother was phenotypically normal, while the younger sister has repolarization abnormalities and frequent ventricular ectopy.
Conclusions: We report a novel PKP2 mutation that causes familial ARVC. All mutation carriers in this kindred group were women, and the family showed incomplete penetrance and variable expression of ARVC. Premature truncation of the plakophilin-2 protein appears to be the predominant mechanism whereby PKP2 mutations elicit the ARVC phenotype.
Comment in
- Arrhythmogenic right ventricular cardiomyopathy: how should genetic information be integrated with clinical diagnostic criteria?Kaufman ES.Kaufman ES.Heart Rhythm. 2006 Aug;3(8):945-7. doi: 10.1016/j.hrthm.2006.05.009. Epub 2006 May 9.Heart Rhythm. 2006.PMID:16876744No abstract available.
Similar articles
- Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.Dalal D, James C, Devanagondi R, Tichnell C, Tucker A, Prakasa K, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP.Dalal D, et al.J Am Coll Cardiol. 2006 Oct 3;48(7):1416-24. doi: 10.1016/j.jacc.2006.06.045. Epub 2006 Sep 12.J Am Coll Cardiol. 2006.PMID:17010805
- Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, van der Smagt J, Boven LG, Mannens MM, van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA, Rodriguez LM, van Gelder IC, Hauer RN.van Tintelen JP, et al.Circulation. 2006 Apr 4;113(13):1650-8. doi: 10.1161/CIRCULATIONAHA.105.609719. Epub 2006 Mar 27.Circulation. 2006.PMID:16567567
- Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.Syrris P, Ward D, Asimaki A, Sen-Chowdhry S, Ebrahim HY, Evans A, Hitomi N, Norman M, Pantazis A, Shaw AL, Elliott PM, McKenna WJ.Syrris P, et al.Circulation. 2006 Jan 24;113(3):356-64. doi: 10.1161/CIRCULATIONAHA.105.561654. Epub 2006 Jan 16.Circulation. 2006.PMID:16415378
- Arrhythmogenic right ventricular cardiomyopathy: reassessing the link with the desmosome.Zhang M, Tavora F, Li L, Fowler D, Zhao Z, Burke A.Zhang M, et al.Pathology. 2012 Dec;44(7):596-604. doi: 10.1097/PAT.0b013e32835a0163.Pathology. 2012.PMID:23089739Review.
- Autosomal Recessive Nonsyndromic Arrhythmogenic Right Ventricular Cardiomyopathy without Cutaneous Involvements: A Novel Mutation.Soveizi M, Rabbani B, Rezaei Y, Saedi S, Najafi N, Maleki M, Mahdieh N.Soveizi M, et al.Ann Hum Genet. 2017 Jul;81(4):135-140. doi: 10.1111/ahg.12193. Epub 2017 May 19.Ann Hum Genet. 2017.PMID:28523642Review.
Cited by
- Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.Lainscak M, Anker SD.Lainscak M, et al.Herz. 2009 Mar;34(2):141-7. doi: 10.1007/s00059-009-3211-z.Herz. 2009.PMID:19370331Review.
- Tracking footprints of artificial and natural selection signatures in breeding and non-breeding cats.Zhang X, Jamwal K, Distl O.Zhang X, et al.Sci Rep. 2022 Oct 27;12(1):18061. doi: 10.1038/s41598-022-22155-7.Sci Rep. 2022.PMID:36302822Free PMC article.
- Novel mutations in arrhythmogenic right ventricular cardiomyopathy from Indian population.Pamuru PR, Maithili DV, Mohiuddin K, Calambur N, Nallari P.Pamuru PR, et al.Indian J Hum Genet. 2011 May;17(2):70-6. doi: 10.4103/0971-6866.86182.Indian J Hum Genet. 2011.PMID:22090716Free PMC article.
- Cell-cell connection to cardiac disease.Sheikh F, Ross RS, Chen J.Sheikh F, et al.Trends Cardiovasc Med. 2009 Aug;19(6):182-90. doi: 10.1016/j.tcm.2009.12.001.Trends Cardiovasc Med. 2009.PMID:20211433Free PMC article.Review.
- Scaling up single-cell mechanics to multicellular tissues - the role of the intermediate filament-desmosome network.Broussard JA, Jaiganesh A, Zarkoob H, Conway DE, Dunn AR, Espinosa HD, Janmey PA, Green KJ.Broussard JA, et al.J Cell Sci. 2020 Mar 16;133(6):jcs228031. doi: 10.1242/jcs.228031.J Cell Sci. 2020.PMID:32179593Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources